Introduction
In a previous paper our Institute of Medical Ethics working party argued that on rare occasions a doctor is ethically justified in assisting the death of a patient, but only when asked to do so by the patient whose terminal suffering cannot be relieved in any other way (1) . In a subsequent paper the working party considered the plight of individuals in the persistent vegetative state and concluded that it may be morally justified to withdraw artificial nutrition and hydration in circumstances where the diagnosis and prognosis are beyond doubt, and where doctors, other 
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carers and the family agree that continued survival cannot be in the patient's interest (2) . In this paper we consider the particular problems posed by infants whose lives may be prolonged through modem methods of treatment but for whom there is no prospect of recovery without profound disability. While recognising that cultural and national differences exist in the approach to matters relating to 'end of life' decisions (3,4), we, nevertheless, concentrate on the British scene with brief reference to current controversies in the United States.
Decisions involving infants
Infants obviously lack the capacity to request the withholding or withdrawing of life-sustaining treatment and they are patients for whom no 'substituted judgment' can be rendered as their present and past wishes cannot possibly be known. If decisions to allow the death of such vulnerable patients are to be justified ethically, three important questions must be addressed: first, in what clinical situations are such decisions appropriate; second, who should be responsible for decisions of such fundamental importance; and third, by what process should they be made so that the interests of the infants are fully protected?
Which infants are involved?
When dilemmas about resuscitation and lifeprolonging treatment for infants first came to wide professional and public attention in the early 1970s, the main focus of concern was on infants born with major congenital abnormalities, particularly of the central nervous system (5, 6) . Since then, advances in prenatal diagnosis and in neonatal intensive care have led to an increase in the relative importance of problems posed by tiny infants whose future quality of life has been severely compromised by the complications of extremely premature birth. Other infants for whom withdrawal of life-prolonging treatment might be considered ethically justified include those whose brains have been damaged by infection, haemorrhage, or by hypoxic-ischaemic encephalopathy. As treatments become increasingly sophisticated, furthermore, it may no longer be appropriate to talk simply of brain damage; but rather to differentiate between various types of neurological disease in the neonate (7) .
For all these infants, irrespective of fine diagnostic distinctions, the basis for any decision to withhold or withdraw life-prolonging treatment is compassionate concern about their future should they survive with devastating brain abnormality or damage. In rare cases, particularly poignant dilemmas arise when the brain remains intact but irreparable damage has occurred to other organs.
Quality of life
To those familiar with neonatal intensive care it is not surprising that concern about quality of life is an important, perhaps the most important, element in these decisions. While doctors and parents can be viewed as partners in decision-making for infants, it must be emphasised that any decision to withhold or withdraw life-sustaining treatment is primarily a medical decision for which the doctor bears ultimate responsibility. Nevertheless, good practice imposes an important duty on doctors to take careful note, not only of the wishes of the family, but of the views of the nurses and other key members of the intensive care team. Like doctors, nurses are accountable for their own practice in the care of patients. By the nature of their work and their frequent and prolonged contacts with parents at the cotside they may be in a better position to understand the true feelings and wishes of grieving parents that may not have found expression during more formal discussions with the medical staff.
When it is clear that there will be no benefit from further intensive treatment and where it seems beyond reasonable doubt that, with survival, the infant will be seriously impaired, there will usually be agreement to withhold or withdraw a life-sustaining procedure such as assisted ventilation. Sometimes parents may disagree with the staff and request withdrawal of treatment earlier than indicated, or occasionally they may insist that treatment be continued long after the doctors and nurses believe it to be futile. Parental wishes should be respected as far as possible but there will be circumstances when they cannot the moral decisions taken on behalf of patients. In the process of establishing the facts of diagnosis and prognosis doctors consult with specialist colleagues in the same way as the family consult with their own advisers. The nurses who provide the hour-to-hour care at the cotside are in almost constant communication with parents as together they watch anxiously over the condition of the infant, and become fiercely protective of his or her interests. In modem hospitals, frequent staff changes and shift systems sometimes make it difficult to maintain continuity and consistency in patient care. But by such a process of consultation through which an appropriate environment is established, the decisions taken should be both medically and morally consistent.
ETHICS COMMITTEES
In attempting to reach a compromise over the Baby Doe regulations, and to avoid intrusive review by federal investigators, American paediatricians proposed the use of Institutional Ethics Committees within the major hospitals to ensure a broader forum for discussion of the issues involved (11). These committees, and particularly some of the individual members, can be very helpful to the staff in an extremely taxing and poignant aspect of their work. We believe that ethics committees should remain advisory and not be asked or expected to take decisions on individual cases, a pitfall some American committees have not managed to avoid. The final decision should remain the prerogative of the doctor in clinical charge. There is always the danger that a committee, being relatively remote from the realities of abnormal birth and intensive care, will end up making a decision that is more protective of other interests than those of the individual child and family (12) . Many British neonatologists already use a multidisciplinary group informally to discuss difficult cases at length and some are considering the formation of a more formal committee structure quite distinct from the research ethics committees already established in major hospitals. Apart from a role in educating both committee members and staff, and in reviewing hospital practices and developing policy, a formal forum for the regular discussion of these complex problems can also provide 'ethical comfort' and possibly some legal protection for the doctors who bear the ultimate responsibility. Whether ethics committees ensure better decision-making is less certain, but the need for them should diminish as good multidisciplinary practice continues to evolve.
RECORDS
A final protection is to insist that all decisions and actions taken are accurately recorded in such a manner that the decision-making process can be reviewed. Full explanation of the circumstances and reasons for any decision to withdraw treatment can do much to demonstrate and justify the trustworthiness that must remain a key component in medical decision-making.
Legal implications
One legacy of legislation in the United States has been the widespread but mistaken belief among American paediatricians that the law requires that all infants be treated intensively until death is certain (13) . As a result, terminally ill infants have received overly aggressive and futile treatment for long periods at great cost, both human and financial. The Baby Doe regulations simply require that States wishing to receive federal funds for child protection services must have established a mechanism to review suspected cases of 'medical neglect'. To paediatricians and parents it may seem offensive to have their carefully considered decisions to withhold or withdraw life-prolonging treatments subject to scrutiny as 'child abuse'. They have, nonetheless, retained considerable discretion in decision-making.
The same is true in the UK. One lawyer, somewhat cynically, has described the current position thus: 'In so far as the tradition has been for the courts in the United Kingdom to allow themselves to be led by the medical profession, it is not necessarily surprising that both appear to pay lip service to the sanctity of life while leaving a vast discretion to the doctor in charge in consultation with the parents' (14) .
Some examples of this 'vast discretion' are given below but the fact remains that for any decision to withhold or withdraw life-prolonging treatment, the legal position of the doctor remains somewhat unclear in the absence of any testing in court. A neonatologist will remain legally vulnerable as long as it is thought unwise (and probably impossible) to detail all the circumstances where it is 'legal' to allow a baby to die.
Recent court decisions give some idea of how English law currently views the responsibilities of doctors for making decisions about life-prolonging and life-saving treatment for children. They are consistent with the view expressed earlier, viz that quality of life judgments are proper components of the decision-making process.
For example, in Re B heard by the Court of Appeal in 1981, surgery was authorised to correct congenital intestinal obstruction in an infant with Down's Syndrome in the face of parental objection because, in the judges' opinion, the infant's life was not so 'demonstrably awful' that the infant should be allowed to die (15) .
In 1989, in Re C, a High Court judge agreed that a very seriously handicapped infant should be permitted to die and that no further attempts should be made to prolong her life. She was four months old, hydrocephalic, blind, and with severe cerebral palsy. This decision was appealed by the Official Solicitor who was unhappy with the judge's use of the phrase 'treat to die' which might be interpreted as giving authority for taking active steps to end the child's life. In their judgment, the Lords of Appeal agreed that Mr Justice Ward had 'failed to express himself with his usual felicity' and that the original decision had been too restrictive on the exercise of the doctors' 'normal clinical discretion'. They accepted that the goal of any treatment should be to ease the baby's suffering rather than a short prolongation of her life (16) .
This case only came to attention because the baby, for reasons unconnected with her medical condition, had been made a ward of court before birth, but it provides further insights into how judges view these treatment dilemmas. Mr Justice Ward referred to Baby B noted earlier and also indicated his agreement with the kinds of criteria that have been used (and published) by neonatologists during the past two decades: 'In as much as one judges, as I do, intellectual function to be a hallmark of our humanity, her functioning on that level is negligible if it exists at all. Coupled with her total physical handicap, the quality of her life will be demonstrably awful and intolerable within the B test'.
In Re C the issue was about life-prolonging as distinct from life-saving treatment, that is, it was about a baby who was dying. In a subsequent 1990 case, that of Baby 7, the Official Solicitor appealed a decision by Mr Justice Scott Baker that doctors should not be required to ventilate and therefore save the life of a 'gravely ill child', should he suffer a collapse, on the basis that: 'a court is never justified in withholding consent to treatment which could enable the child to survive a life-threatening condition, whatever the quality of life which it would experience thereafter' (17) .
However, this submission was not accepted by the Court ofAppeal which took the view that there can be some circumstances where the quality of life would be so intolerable that treatment, without which death would ensue, could be withheld even though the child was not dying. Lord Donaldson emphasised the need to avoid looking at the problem from the point ofview of the decision-makers, but instead to look at it from the point of view of the patient.
'... even very severely handicapped people find a quality of life rewarding which to the unhandicapped may seem manifestly intolerable. People have an amazing adaptability. But in the end there will be cases in which the answer must be that it is not in the interests of the child to subject it to treatment which will cause increased suffering and produce no commensurate benefit, giving the fullest possible weight to the child's and mankind's desire to survive'.
This case is also important as it involved an infant born prematurely at 27 weeks gestation who, after weeks of intensive care and many complications was known to have suffered brain damage. 
Consequences
It must be remembered that it is the parents who usually bear the consequences of these clinical decisions and that the supports and services available to help families to cope are often unsatisfactory or inadequate. On the death of an infant parents experience acute and profound grief, perhaps with feelings of guilt at the tragic outcome of a pregnancy that promised so much. For many families the long term consequences of an infant surviving with grievous handicap are likely to be even more devastating as the crushing burdens and 'chronic sorrow' of long term care become all too apparent. Supportive care and counselling will be necessary not only in the hospital but within the community, perhaps for many years but certainly long after the staff in the neonatal unit have turned to other problems. It is part of the wide responsibility of the intensive care team to facilitate access to these services, perhaps with the help of the social worker or hospital chaplain. Members of the team can also be influential in lobbying for improved services for disabled children and their families both locally and nationally.
It would appear that with the more open and ongoing discussion of the ethical issues relating to prolonging life, even in countries where there is a tendency to wait for a virtually certain prognosis of impending death before withdrawing treatment, there has been a swing towards a more deliberated approach to decision-making in intensive care units (4, 19) . Consideration of the relative benefits and burdens in each individual case influences the judgment made. In addition, an increasing tendency to resuscitate smaller and more immature infants has made it necessary for neonatologists to countenance withdrawal of treatment when there are clear indications of severely adverse outcomes.
Summary
Doctors may decide to withhold or withdraw treatment and by so doing legitimately allow or assist death when it is agreed between the informed parents (or surrogate) and the members of the intensive care team that continued treatment will lead to unacceptable burdens without compensating benefits for the infant. The responsibility for such a decision ultimately rests with the doctor in clinical charge but he or she has a duty to share the decisionmaking process with those closely involved in the care of the patient. In assessing the benefits and burdens, quality of life judgments are unavoidable if the decision-makers are to act in the best interests of the child. In reaching a decision, considerable latitude should be expected and tolerated. If the decision-making is informed, thorough and properly shared, and recording is accurate and careful, the process itself will help to mitigate the long term consequences for both parents and staff.
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